Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18033
Country/Region: Uganda
Year: 2018
Main Partner: Mildmay International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $12,807,245 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,331,116
Care: Orphans and Vulnerable Children (HKID) $724,868
Care: TB/HIV (HVTB) $372,381
Care: Pediatric Care and Support (PDCS) $619,240
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,687,893
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $746,655
Sexual Prevention: Other Sexual Prevention (HVOP) $3,471,498
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $499,266
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $3,157,029
Treatment: Pediatric Treatment (PDTX) $197,299
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 64
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 38
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 35
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 173
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 121
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 62
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 1,495
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 1,113
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 152
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 42
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 727
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 340
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 362
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 144
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 268
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 24
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 186
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 268
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 24
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 186
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 268
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 24
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 186
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 91
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 62
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 191
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 14
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 117
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 9
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 584
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 4,893
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 1,943
GEND_GBV Number of people receiving post-GBV care 2019 6,836
HTS_SELF 15-19, Female, Directly-Assisted 2019 229
HTS_SELF 15-19, Female, Unassisted 2019 604
HTS_SELF 20-24, Female, Directly-Assisted 2019 602
HTS_SELF 20-24, Female, Unassisted 2019 1,812
HTS_SELF 20-24, Male, Directly-Assisted 2019 31
HTS_SELF 20-24, Male, Unassisted 2019 31
HTS_SELF 25-29, Female, Directly-Assisted 2019 363
HTS_SELF 25-29, Female, Unassisted 2019 1,208
HTS_SELF 25-29, Male, Directly-Assisted 2019 31
HTS_SELF 25-29, Male, Unassisted 2019 31
HTS_SELF 30-34, Female, Directly-Assisted 2019 205
HTS_SELF 30-34, Female, Unassisted 2019 483
HTS_SELF 35-39, Female, Directly-Assisted 2019 84
HTS_SELF 35-39, Female, Unassisted 2019 241
HTS_SELF 40-49, Female, Directly-Assisted 2019 24
HTS_SELF 40-49, Female, Unassisted 2019 60
HTS_SELF FSW, Directly-Assisted 2019 301
HTS_SELF FSW, Unassisted 2019 905
HTS_SELF MSM, Directly-Assisted 2019 60
HTS_SELF MSM, Unassisted 2019 60
HTS_SELF Unassisted - Sex Partner 2019 6,039
HTS_TST <5, Unknown Sex, Negative 2019 1,202
HTS_TST 15-19, Female, Negative 2019 323
HTS_TST 15-19, Male, Negative 2019 105
HTS_TST 20-24, Female, Negative 2019 598
HTS_TST 20-24, Male, Negative 2019 267
HTS_TST 25-29, Female, Negative 2019 1,269
HTS_TST 25-29, Female, Negative 2019 2,128
HTS_TST 25-29, Female, Negative 2019 4,032
HTS_TST 25-29, Female, Negative 2019 952
HTS_TST 25-29, Female, Negative 2019 11,197
HTS_TST 25-29, Female, Negative 2019 17,868
HTS_TST 25-29, Female, Negative 2019 728
HTS_TST 25-29, Female, Negative 2019 82
HTS_TST 25-29, Male, Negative 2019 1,040
HTS_TST 25-29, Male, Negative 2019 1,406
HTS_TST 25-29, Male, Negative 2019 3,307
HTS_TST 25-29, Male, Negative 2019 781
HTS_TST 25-29, Male, Negative 2019 11,517
HTS_TST 25-29, Male, Negative 2019 490
HTS_TST 25-29, Male, Negative 2019 49
HTS_TST 25-29, Male, Negative 2019 16,121
HTS_TST 30-34, Female, Negative 2019 303
HTS_TST 30-34, Female, Negative 2019 922
HTS_TST 30-34, Female, Negative 2019 961
HTS_TST 30-34, Female, Negative 2019 227
HTS_TST 30-34, Female, Negative 2019 4,008
HTS_TST 30-34, Female, Negative 2019 7,732
HTS_TST 30-34, Female, Negative 2019 323
HTS_TST 30-34, Female, Negative 2019 99
HTS_TST 30-34, Male, Negative 2019 803
HTS_TST 30-34, Male, Negative 2019 933
HTS_TST 30-34, Male, Negative 2019 2,552
HTS_TST 30-34, Male, Negative 2019 602
HTS_TST 30-34, Male, Negative 2019 7,386
HTS_TST 30-34, Male, Negative 2019 327
HTS_TST 30-34, Male, Negative 2019 66
HTS_TST 30-34, Male, Negative 2019 2,149
HTS_TST 35-39, Female, Negative 2019 569
HTS_TST 35-39, Female, Negative 2019 957
HTS_TST 35-39, Female, Negative 2019 1,811
HTS_TST 35-39, Female, Negative 2019 426
HTS_TST 35-39, Female, Negative 2019 4,423
HTS_TST 35-39, Female, Negative 2019 8,028
HTS_TST 35-39, Female, Negative 2019 333
HTS_TST 35-39, Female, Negative 2019 125
HTS_TST 35-39, Male, Negative 2019 953
HTS_TST 35-39, Male, Negative 2019 1,259
HTS_TST 35-39, Male, Negative 2019 3,032
HTS_TST 35-39, Male, Negative 2019 716
HTS_TST 35-39, Male, Negative 2019 8,361
HTS_TST 35-39, Male, Negative 2019 440
HTS_TST 35-39, Male, Negative 2019 197
HTS_TST 35-39, Male, Negative 2019 2,149
HTS_TST 40-49, Female, Negative 2019 441
HTS_TST 40-49, Female, Negative 2019 646
HTS_TST 40-49, Female, Negative 2019 1,661
HTS_TST 40-49, Female, Negative 2019 393
HTS_TST 40-49, Female, Negative 2019 3,590
HTS_TST 40-49, Female, Negative 2019 5,409
HTS_TST 40-49, Female, Negative 2019 225
HTS_TST 40-49, Female, Negative 2019 82
HTS_TST 40-49, Male, Negative 2019 1,207
HTS_TST 40-49, Male, Negative 2019 1,172
HTS_TST 40-49, Male, Negative 2019 3,834
HTS_TST 40-49, Male, Negative 2019 903
HTS_TST 40-49, Male, Negative 2019 6,776
HTS_TST 40-49, Male, Negative 2019 410
HTS_TST 40-49, Male, Negative 2019 82
HTS_TST 40-49, Male, Negative 2019 2,149
HTS_TST 50+, Female, Negative 2019 11
HTS_TST 50+, Male, Negative 2019 197
HTS_TST By Key Population: FSW, Negative 2019 2,949
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 9,086
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 326,531
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 818
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 893
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 190
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 183
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 91
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 124
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 341
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 2
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 387
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 778
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 389
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 520
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 1,445
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 1,635
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 15,452
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 26,830
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 818
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 893
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 190
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 245
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 124
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 410
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 455
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 4
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 351
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 3,480
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 3,802
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 809
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 920
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 299
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,706
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 764
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 21
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 574
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 6,335
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 6,919
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 1,460
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 4,576
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 2,285
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 6,876
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 7,379
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 83
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 3,170
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 9,808
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 82
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 32
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 17
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 115
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 168
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 197
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 82
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 49
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 115
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 2,687
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 13,433
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 13,433
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 1,612
HTS_TST_POS <5, Unknown Sex, Positive 2019 50
HTS_TST_POS 15-19, Female, Positive 2019 26
HTS_TST_POS 15-19, Male, Positive 2019 10
HTS_TST_POS 20-24, Female, Positive 2019 45
HTS_TST_POS 20-24, Male, Positive 2019 21
HTS_TST_POS 25-29, Female, Positive 2019 224
HTS_TST_POS 25-29, Female, Positive 2019 111
HTS_TST_POS 25-29, Female, Positive 2019 169
HTS_TST_POS 25-29, Female, Positive 2019 169
HTS_TST_POS 25-29, Female, Positive 2019 346
HTS_TST_POS 25-29, Female, Positive 2019 571
HTS_TST_POS 25-29, Female, Positive 2019 56
HTS_TST_POS 25-29, Female, Positive 2019 41
HTS_TST_POS 25-29, Male, Positive 2019 183
HTS_TST_POS 25-29, Male, Positive 2019 74
HTS_TST_POS 25-29, Male, Positive 2019 137
HTS_TST_POS 25-29, Male, Positive 2019 137
HTS_TST_POS 25-29, Male, Positive 2019 357
HTS_TST_POS 25-29, Male, Positive 2019 38
HTS_TST_POS 25-29, Male, Positive 2019 23
HTS_TST_POS 25-29, Male, Positive 2019 45
HTS_TST_POS 30-34, Female, Positive 2019 53
HTS_TST_POS 30-34, Female, Positive 2019 47
HTS_TST_POS 30-34, Female, Positive 2019 40
HTS_TST_POS 30-34, Female, Positive 2019 40
HTS_TST_POS 30-34, Female, Positive 2019 125
HTS_TST_POS 30-34, Female, Positive 2019 444
HTS_TST_POS 30-34, Female, Positive 2019 26
HTS_TST_POS 30-34, Female, Positive 2019 49
HTS_TST_POS 30-34, Male, Positive 2019 141
HTS_TST_POS 30-34, Male, Positive 2019 48
HTS_TST_POS 30-34, Male, Positive 2019 106
HTS_TST_POS 30-34, Male, Positive 2019 106
HTS_TST_POS 30-34, Male, Positive 2019 228
HTS_TST_POS 30-34, Male, Positive 2019 26
HTS_TST_POS 30-34, Male, Positive 2019 33
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 100
HTS_TST_POS 35-39, Female, Positive 2019 50
HTS_TST_POS 35-39, Female, Positive 2019 76
HTS_TST_POS 35-39, Female, Positive 2019 76
HTS_TST_POS 35-39, Female, Positive 2019 136
HTS_TST_POS 35-39, Female, Positive 2019 190
HTS_TST_POS 35-39, Female, Positive 2019 27
HTS_TST_POS 35-39, Female, Positive 2019 60
HTS_TST_POS 35-39, Male, Positive 2019 169
HTS_TST_POS 35-39, Male, Positive 2019 65
HTS_TST_POS 35-39, Male, Positive 2019 127
HTS_TST_POS 35-39, Male, Positive 2019 127
HTS_TST_POS 35-39, Male, Positive 2019 259
HTS_TST_POS 35-39, Male, Positive 2019 35
HTS_TST_POS 35-39, Male, Positive 2019 97
HTS_TST_POS 35-39, Male, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 78
HTS_TST_POS 40-49, Female, Positive 2019 36
HTS_TST_POS 40-49, Female, Positive 2019 70
HTS_TST_POS 40-49, Female, Positive 2019 70
HTS_TST_POS 40-49, Female, Positive 2019 111
HTS_TST_POS 40-49, Female, Positive 2019 65
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Female, Positive 2019 41
HTS_TST_POS 40-49, Male, Positive 2019 214
HTS_TST_POS 40-49, Male, Positive 2019 62
HTS_TST_POS 40-49, Male, Positive 2019 159
HTS_TST_POS 40-49, Male, Positive 2019 159
HTS_TST_POS 40-49, Male, Positive 2019 210
HTS_TST_POS 40-49, Male, Positive 2019 30
HTS_TST_POS 40-49, Male, Positive 2019 41
HTS_TST_POS 40-49, Male, Positive 2019 6
HTS_TST_POS 50+, Female, Positive 2019 2
HTS_TST_POS 50+, Male, Positive 2019 15
HTS_TST_POS By Key Population: FSW, Positive 2019 1,515
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 1,965
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 44
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 47
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 68
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 502
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 871
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 47
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 81
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 62
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 115
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 118
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 47
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 90
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 40
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 30
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 135
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 135
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 141
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 214
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 227
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 97
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 200
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 57
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 86
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 97
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 57
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 5
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 11,232
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 5,427
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 16,659
OVC_SERV <1, Unknown Sex, Social Protection 2019 126
OVC_SERV 1-9, Unknown Sex, Social Protection 880 Number of orphans and vulnerable children (<18 years old) whose HIV status is known or unknown by the OVC implementing partner. 8,889 Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 11,855
OVC_SERV Age/Sex: <1 2019 472
OVC_SERV Age/Sex: 1-9 2019 3,321
OVC_SERV Age/Sex: 10-14 Female 2019 1,420
OVC_SERV Age/Sex: 10-14 Male 2019 1,306
OVC_SERV Age/Sex: 15-17 Female 2019 1,302
OVC_SERV Age/Sex: 15-17 Male 2019 1,068
OVC_SERV By: Age/sex: 18-24 Female 2019 1,306
OVC_SERV By: Age/sex: 25+ Female 2019 353
OVC_SERV By: Age/sex: Male 18-24 2019 1,070
OVC_SERV By: Age/sex: Male 25+ 2019 237
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 11,855
OVC_SERV Program Completion: Active 2019 11,264
OVC_SERV Program Completion: Graduation 2019 591
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2019 264
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2019 523
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 25+ 2019 1,833
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2019 211
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2019 420
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 25+ 2019 1,469
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2019 1,927
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2019 480
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2019 1,679
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2019 420
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2019 1,156
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2019 288
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2019 1,008
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2019 252
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2019 377
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2019 57
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2019 348
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2019 47
OVC_SERV Sum of Age/Sex disaggregates 2019 5,096
PMTCT_ART Already on ART at beginning of current pregnancy 2019 3,871
PMTCT_ART New on ART 2019 2,471
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 6,342
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 88,003
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 5,337
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,005
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 6,342
PMTCT_EID Sum of Infant Age disaggregates 2019 6,342
PMTCT_STAT 25-29, Female 2019 19,360
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 1,784
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 16,996
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 580
PMTCT_STAT 30-34, Female 2019 14,961
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 1,379
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 13,133
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 449
PMTCT_STAT 35-39, Female 2019 6,161
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 570
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 5,407
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 184
PMTCT_STAT 40-49, Female 2019 1,760
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 168
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 1,539
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 53
PMTCT_STAT By Age (Numerator): 15-19 2019 16,721
PMTCT_STAT By Age (Numerator): 20-24 2019 29,040
PMTCT_STAT By Number of known positives: 15-19 2019 20
PMTCT_STAT By Number of known positives: 20-24 2019 118
PMTCT_STAT By Number of new negative: 15-19 2019 16,199
PMTCT_STAT By Number of new negative: 20-24 2019 28,051
PMTCT_STAT By Number of new positives: 15-19 2019 502
PMTCT_STAT By Number of new positives: 20-24 2019 871
PMTCT_STAT Number of new ANC and L&D clients 2019 88,003
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 88,003
PMTCT_STAT_den 25-29, Female 2019 19,360
PMTCT_STAT_den 30-34, Female 2019 14,961
PMTCT_STAT_den 35-39, Female 2019 6,161
PMTCT_STAT_den 40-49, Female 2019 1,760
PMTCT_STAT_den By Age (Denominator): <15-19 2019 16,721
PMTCT_STAT_den By Age (Denominator): 20-24 2019 29,040
PP_PREV 25-29, Female 2019 115
PP_PREV 25-29, Male 2019 205
PP_PREV 30-34, Female 2019 102
PP_PREV 30-34, Male 2019 192
PP_PREV 35-39, Female 2019 163
PP_PREV 35-39, Male 2019 299
PP_PREV 40-49, Female 2019 162
PP_PREV 40-49, Male 2019 298
PP_PREV Age/sex: 10-14 Female 2019 97
PP_PREV Age/sex: 15-19 Female 2019 683
PP_PREV Age/sex: 15-19 Male 2019 149
PP_PREV Age/sex: 20-24 Female 2019 392
PP_PREV Age/sex: 20-24 Male 2019 235
PP_PREV Age/sex: 50+ Female 2019 102
PP_PREV Age/sex: 50+ Male 2019 182
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 3,376
PP_PREV Sum of Age/Sex disaggregates 2019 1,840
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 80
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 479
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 73
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 814
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,446
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 177
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 11,067
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 20
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 1,273
TB_PREV By Age/Sex (Numerator): <15, Female 2019 12
TB_PREV By Age/Sex (Numerator): <15, Female 2019 764
TB_PREV By Age/Sex (Numerator): <15, Male 2019 8
TB_PREV By Age/Sex (Numerator): <15, Male 2019 510
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 123
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 7,761
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 59
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 3,689
TB_PREV IPT, Life-long ART, Already, Positive 2019 5
TB_PREV IPT, Life-long ART, Already, Positive 2019 331
TB_PREV IPT, Life-long ART, New, Positive 2019 53
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 12,724
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 202
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 14,972
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 235
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 206
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 13,024
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 23
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 1,498
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 899
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 14
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 599
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 9
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 9,131
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 144
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 68
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 4,343
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 6
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 389
TB_PREV_den IPT, Life-long ART, New, Positive 2019 61
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 154
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 915
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 168
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,851
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 3,088
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 3,088
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 154
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 915
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 168
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,851
TX_CURR 25-29, Female, Positive 2019 7,139
TX_CURR 25-29, Female, Positive 2019 111
TX_CURR 25-29, Male, Positive 2019 1,257
TX_CURR 25-29, Male, Positive 2019 21
TX_CURR 30-34, Female, Positive 2019 10,204
TX_CURR 30-34, Female, Positive 2019 160
TX_CURR 30-34, Male, Positive 2019 2,994
TX_CURR 30-34, Male, Positive 2019 46
TX_CURR 35-39, Female, Positive 2019 8,340
TX_CURR 35-39, Female, Positive 2019 130
TX_CURR 35-39, Male, Positive 2019 3,910
TX_CURR 35-39, Male, Positive 2019 61
TX_CURR 40-49, Female, Positive 2019 12,289
TX_CURR 40-49, Female, Positive 2019 194
TX_CURR 40-49, Male, Positive 2019 10,164
TX_CURR 40-49, Male, Positive 2019 160
TX_CURR Age/Sex: <1 2019 374
TX_CURR Age/Sex: <1 2019 6
TX_CURR Age/Sex: <1-9 2019 2,295
TX_CURR Age/Sex: 1-9 2019 38
TX_CURR Age/Sex: 10-14 Female 2019 1,869
TX_CURR Age/Sex: 10-14 Female 2019 30
TX_CURR Age/Sex: 10-14 Male 2019 799
TX_CURR Age/Sex: 10-14 Male 2019 14
TX_CURR Age/Sex: 15-19 Female 2019 1,689
TX_CURR Age/Sex: 15-19 Female 2019 26
TX_CURR Age/Sex: 15-19 Male 2019 284
TX_CURR Age/Sex: 15-19 Male 2019 5
TX_CURR Age/Sex: 20-24 Female 2019 5,004
TX_CURR Age/Sex: 20-24 Female 2019 78
TX_CURR Age/Sex: 20-24 Male 2019 432
TX_CURR Age/Sex: 20-24 Male 2019 8
TX_CURR Age/Sex: 50+ Female 2019 8,987
TX_CURR Age/Sex: 50+ Female 2019 141
TX_CURR Age/Sex: 50+ Male 2019 5,990
TX_CURR Age/Sex: 50+ Male 2019 94
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 84,020
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 1,323
TX_CURR Sum of age/sex disaggregates 2019 1,973
TX_CURR Sum of Age/Sex disaggregations 2019 31
TX_NEW 25-29, Female, Positive 2019 1,543
TX_NEW 25-29, Female, Positive 2019 22
TX_NEW 25-29, Male, Positive 2019 1,019
TX_NEW 25-29, Male, Positive 2019 13
TX_NEW 30-34, Female, Positive 2019 669
TX_NEW 30-34, Female, Positive 2019 8
TX_NEW 30-34, Male, Positive 2019 678
TX_NEW 30-34, Male, Positive 2019 8
TX_NEW 35-39, Female, Positive 2019 695
TX_NEW 35-39, Female, Positive 2019 8
TX_NEW 35-39, Male, Positive 2019 914
TX_NEW 35-39, Male, Positive 2019 12
TX_NEW 40-49, Female, Positive 2019 468
TX_NEW 40-49, Female, Positive 2019 6
TX_NEW 40-49, Male, Positive 2019 850
TX_NEW 40-49, Male, Positive 2019 12
TX_NEW Breastfeeding status 2019 995
TX_NEW Breastfeeding status 2019 13
TX_NEW By Age/Sex: <1 2019 60
TX_NEW By Age/Sex: <1 2019 2
TX_NEW By Age/Sex: 1-9 2019 379
TX_NEW By Age/Sex: 1-9 2019 10
TX_NEW By Age/Sex: 10-14 Female 2019 350
TX_NEW By Age/Sex: 10-14 Female 2019 10
TX_NEW By Age/Sex: 10-14 Male 2019 88
TX_NEW By Age/Sex: 10-14 Male 2019 3
TX_NEW By Age/Sex: 15-19 Female 2019 669
TX_NEW By Age/Sex: 15-19 Female 2019 8
TX_NEW By Age/Sex: 15-19 Male 2019 217
TX_NEW By Age/Sex: 15-19 Male 2019 3
TX_NEW By Age/Sex: 20-24 Female 2019 1,239
TX_NEW By Age/Sex: 20-24 Female 2019 16
TX_NEW By Age/Sex: 20-24 Male 2019 554
TX_NEW By Age/Sex: 20-24 Male 2019 7
TX_NEW By Age/Sex: 50+ Female 2019 25
TX_NEW By Age/Sex: 50+ Male 2019 406
TX_NEW By Age/Sex: 50+ Male 2019 5
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 10,823
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 153
TX_NEW Pregnancy status 2019 995
TX_NEW Pregnancy status 2019 13
TX_NEW Sum of Age/Sex disaggregates 2019 3,548
TX_NEW Sum of Age/Sex disaggregates 2019 52
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 75,619
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 1,190
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 3,024
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 48
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 415
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 7
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 1,511
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 23
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 205
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 41,593
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 655
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 6,268
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 98
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 19,660
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 310
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 2,943
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 46
TX_PVLS_den Denominator: Indication: Routine 2019 65,788
TX_PVLS_den Denominator: Indication: Routine 2019 1,036
TX_PVLS_den Denominator: Indication: Targeted 2019 9,831
TX_PVLS_den Denominator: Indication: Targeted 2019 154
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 151
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 4
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 81
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 8,312
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 89
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 7,374
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 77
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 15,918
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 173
TX_RET Numerator by Status: Breastfeeding 2019 1,569
TX_RET Numerator by Status: Breastfeeding 2019 17
TX_RET Numerator by Status: Pregnant 2019 1,569
TX_RET Numerator by Status: Pregnant 2019 17
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 17,688
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 191
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 167
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 6
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 90
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 9,239
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 96
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 8,192
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 86
TX_RET_den Denominator by Status: Breastfeeding 2019 1,744
TX_RET_den Denominator by Status: Breastfeeding 2019 17
TX_RET_den Denominator by Status: Pregnant 2019 1,744
TX_RET_den Denominator by Status: Pregnant 2019 17
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 84,020
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 1,323
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 5,041
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 80
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 3,362
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 52
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 807
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 384
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 51,250
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 24,367
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 2,521
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 38
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 169
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 2
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 672
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 12
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 52
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 3,362
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 73,098
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 1,152
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 2,185
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 34
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 8,402
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 132
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 335
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 5
VMMC_CIRC 30-34, Male 2019 2,156
VMMC_CIRC 35-39, Male 2019 2,156
VMMC_CIRC 40-49, Male 2019 2,156
VMMC_CIRC By Age: 10-14 2019 2,694
VMMC_CIRC By Age: 15-19 2019 13,473
VMMC_CIRC By Age: 20-24 2019 13,473
VMMC_CIRC By Age: 25-29 2019 16,167
VMMC_CIRC By Age: 50+ 2019 1,612
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 53,887
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 53,887
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 47,419
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 31,252
Cross Cutting Budget Categories and Known Amounts Total: $3,734,213
Gender: Gender Based Violence (GBV) $350,000
GBV Prevention
Gender: Gender Equality $75,000
Equity in HIV prevention, care, treatment and support
Water $78,679
Adolescent Girls and Young Women (AGYW) $3,230,534